发明授权
- 专利标题: BISARYL-SULFONAMIDES
- 专利标题(中): 二芳基磺酰胺
-
申请号: EP05790029.2申请日: 2005-08-11
-
公开(公告)号: EP1786782B1公开(公告)日: 2010-03-31
- 发明人: BERGERON, Philippe , FARTHING, Christopher N. , JONES, Stuart D. , LIEBESCHUETZ, John W. , LIVELY, Sarah E. , MCGEE, Lawrence R. , MCKENDRY, Sharon , SHEPPARD, David , YOUNG, Stephen C.
- 申请人: Amgen Inc.
- 申请人地址: One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 专利权人: Amgen Inc.
- 当前专利权人: Amgen Inc.
- 当前专利权人地址: One Amgen Center Drive Thousand Oaks, CA 91320-1799 US
- 代理机构: Jones Day
- 优先权: US601578P 20040812
- 国际公布: WO2006020830 20060223
- 主分类号: C07D239/48
- IPC分类号: C07D239/48
摘要:
Compounds, compositions and methods are provided that are useful in. the treatment or preventionTof a condition or disorder mediated by PPARϜ or PPARδ. In particular, the compounds of the invention modulate the function of PPARϜ or PPARδ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis. The subject, compounds include bisaryl-sulfonamides that have general formula (I): wherein Ar, R1, X, Y, Z. W, L, B and R2 are described herein.
公开/授权文献
- EP1786782A2 BISARYL-SULFONAMIDES 公开/授权日:2007-05-23
信息查询